4401 - 4410 of 8654 Results
Title
Year
- Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension2016OPENTitle: Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotensionJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-016-0665-5Best OA location URL: https://bmcneurol.biomedcentral.com/track/pdf/10.1186/s12883-016-0665-5Citation Count: 4
-
OPENTitle: Clinimetric testing of the comprehensive cervical dystonia rating scaleJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 4Start Page: 563End Page: 569Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26534Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4833533Citation Count: 46
- Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings2016OPENTitle: Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy FindingsJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 2Start Page: 250End Page: 256Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26476Citation Count: 77
- Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease2016OPENTitle: Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 7Start Page: 1012End Page: 1019Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26621Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4931950Citation Count: 34
-
OPENTitle: Clinical and demographic characteristics related to onset site and spread of cervical dystoniaJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 12Start Page: 1874End Page: 1882Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26817Best OA location URL: http://doi.org/10.1002/mds.26817Citation Count: 43
-
OPENTitle: Assessing medication role on neuropathological findings in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 5Start Page: 613End Page: 614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26536Best OA location URL: http://doi.org/10.1002/mds.26536Citation Count: 0
- Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)2009OPENTitle: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 17Start Page: 4967End Page: 4970Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072Best OA location URL: https://doi.org/10.7270/q2tb16zxCitation Count: 36
- Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?2016OPENTitle: Subliminal gait initiation deficits in rapid eye movement sleep behavior disorder: A harbinger of freezing of gait?Journal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 11Start Page: 1711End Page: 1719Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26665Best OA location URL: http://doi.org/10.1002/mds.26665Citation Count: 41
-
OPENTitle: Role of Elongation and Secondary Pathways in S6 Amyloid Fibril GrowthJournal Name: Biophysical JournalPublisher: Elsevier BVVol: 102Issue #: 9Start Page: 2167End Page: 2175Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.bpj.2012.03.047Best OA location URL: http://www.cell.com/article/S0006349512003888/pdfCitation Count: 36
- Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators2008OPENTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulatorsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 18Issue #: 20Start Page: 5626End Page: 5630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.08.087Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3182458Citation Count: 58